, or Kadai is a Japanese national university located in Kagoshima, Kagoshima Prefecture, Japan. There are three campuses: Shimoarata: Faculty of Fisheries Sakuragaoka: Faculty of Medicine Korimoto: Faculties of Engineering, Science, Agriculture, Education, Humanities and Literature The University's Nansei-Toko Observatory for Earthquakes and Volcanoes is represented on the national Coordinating Committee for Earthquake Prediction. Wikipedia.
Kadokawa J.-I.,Kagoshima University
Precision polysaccharide synthesis by enzymatic catalysis are overviewed that include significant studies on the enzymatic synthesis of oligosaccharides. As the enzymatic glycosylations proceed with highly controlled stereo- and regioselectivities, the poly- and oligosaccharides with well-defined structure have efficiently been synthesized. Due to the production of the structurally defined saccharide chains by the enzymatic catalysis, the strict control of their higher-ordered assemblies is achieved. The enzymatic polysaccharide synthesis is found to have advantage over the conventional chemical process. These include the reactions proceed under the mild conditions in aqueous media and renewable resources from natural and related sources can be employed as the substrates of the reactions. Source
Kagoshima University | Date: 2014-02-14
[Problem] The purpose of the present invention is to provide a pharmaceutical composition containing an antibacterial agent, which is effective in elucidating one cause of dementia, and in treatment thereof. [Solution] The present invention provides a pharmaceutical composition for treatment of dementia, containing an antibacterial agent. The present invention moreover provides a pharmaceutical composition for treatment of extreme halophile infections, containing a folic acid synthesis inhibitor.
Kagoshima University | Date: 2015-09-11
This invention relates to a pharmaceutical composition for inhibiting the growth and/or metastasis of invasive pancreatic cancer in a subject, comprising a molecular-targeted anticancer agent and a pharmaceutically acceptable carrier, wherein the molecular-targeted anticancer agent is a conjugate of a toxin or cytotoxic agent and an antibody or fragment thereof which immunologically and specifically binds to a cell-surface folate receptor (FR) protein of an FR (+) macrophage that exists around pancreatic cancer cells at the invasive front, and to a diagnostic agent and kit for determining the degree of malignancy of pancreatic cancer or the presence of invasive pancreatic cancer, characterized by determining that the cancer tissue is invasive and metastatic when FR (+) macrophage is distributed around pancreatic cancer cells at the invasive front.
French Institute of Health, Medical Research, University of Rouen and Kagoshima University | Date: 2014-04-16
The present invention relates to antibodies which bind human ghrelin and their use in methods of treating or preventing reduced appetite. The invention further relates to diagnostic tools for determining whether an individual is likely to respond to a method of treating or preventing reduced appetite.
Kagoshima University and Kabushiki Kaisha Yaskawa Denki | Date: 2015-11-20
A training device for training a limb includes target parts to be touched with the limb and a force generator that generates a lifting force acting upward on the limb by electricity in a manner allowing the limb to move upward and downward.